Bill Text: NY S09192 | 2023-2024 | General Assembly | Introduced


Bill Title: Provides outpatient insurance coverage for non-opioid treatment of chronic pain including complementary and integrative treatments.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced) 2024-05-03 - REFERRED TO INSURANCE [S09192 Detail]

Download: New_York-2023-S09192-Introduced.html



                STATE OF NEW YORK
        ________________________________________________________________________

                                          9192

                    IN SENATE

                                       May 3, 2024
                                       ___________

        Introduced  by  Sen.  RIVERA -- read twice and ordered printed, and when
          printed to be committed to the Committee on Insurance

        AN ACT to amend the insurance law, in relation  to  providing  insurance
          coverage for chronic pain

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Subsection (i) of section 3216  of  the  insurance  law  is
     2  amended by adding a new paragraph 39 to read as follows:
     3    (39) (A) Every policy that provides medical, major medical, or similar
     4  comprehensive-type  coverage  that provides coverage for pain management
     5  services shall provide outpatient coverage for non-opioid  treatment  of
     6  chronic  pain including complementary and integrative treatments. Access
     7  to non-opioid treatment shall be comparable to  that  of  other  covered
     8  services. Coverage shall be comparable for services provided by licensed
     9  professionals.
    10    (B)  Coverage under this subsection shall not apply financial require-
    11  ments or treatment limitations to non-opioid treatment of  chronic  pain
    12  that  are more restrictive than either of the following: the predominant
    13  financial requirements and treatment limitations applied to substantial-
    14  ly all medical benefits covered  by  the  contract;  and  the  financial
    15  requirements  and  treatment  limitations  applied  to  any opioid-based
    16  treatment of chronic pain.
    17    (C) For the purposes of this paragraph the following terms shall  have
    18  the following meanings:
    19    (i)  "financial  requirement"  means deductible, co-payments, co-insu-
    20  rance and out-of-pocket expenses;
    21    (ii) "predominant" means that a  financial  requirement  or  treatment
    22  limitation  is  the  most  common  or  frequent of such type of limit or
    23  requirement;
    24    (iii) "treatment limitation" means limits on the frequency  of  treat-
    25  ment, number of visits, days of coverage, or other similar limits on the
    26  scope  or  duration of treatment and includes non-quantitative treatment
    27  limitations such as: medical management standards limiting or  excluding
    28  benefits  based  on medical necessity, or based on whether the treatment

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD15062-01-4

        S. 9192                             2

     1  is experimental or investigational; standards for provider admission  to
     2  participate  in  a  network,  including reimbursement rates; methods for
     3  determining usual, customary and reasonable charges; exclusions based on
     4  failure  to  complete  a  course of treatment; and restrictions based on
     5  geographic location, facility type, provider specialty, and other crite-
     6  ria that limit the scope or duration of benefits for  services  provided
     7  under the contract; and
     8    (iv)  "Chronic  pain" means pain that persists or recurs for more than
     9  three months.
    10    § 2. Subsection (l) of section 3221 of the insurance law is amended by
    11  adding a new paragraph 22 to read as follows:
    12    (22) (A) Every insurer delivering a group or blanket policy or issuing
    13  a group or blanket policy for  delivery  in  this  state  that  provides
    14  coverage  for pain management services shall provide outpatient coverage
    15  for non-opioid treatment of chronic  pain  including  complementary  and
    16  integrative treatments. Access to non-opioid treatment shall be compara-
    17  ble  to that of other covered services. Coverage shall be comparable for
    18  services provided by licensed professionals.
    19    (B) Coverage under this subsection shall not apply financial  require-
    20  ments  or  treatment limitations to non-opioid treatment of chronic pain
    21  that are more restrictive than either of the following: the  predominant
    22  financial requirements and treatment limitations applied to substantial-
    23  ly  all  medical  benefits  covered  by  the contract; and the financial
    24  requirements and  treatment  limitations  applied  to  any  opioid-based
    25  treatment of chronic pain.
    26    (C)  For the purposes of this paragraph the following terms shall have
    27  the following meanings:
    28    (i) "financial requirement" means  deductible,  co-payments,  co-insu-
    29  rance and out-of-pocket expenses;
    30    (ii)  "predominant"  means  that  a financial requirement or treatment
    31  limitation is the most common or frequent  of  such  type  of  limit  or
    32  requirement;
    33    (iii)  "treatment  limitation" means limits on the frequency of treat-
    34  ment, number of visits, days of coverage, or other similar limits on the
    35  scope or duration of treatment and includes  non-quantitative  treatment
    36  limitations  such as: medical management standards limiting or excluding
    37  benefits based on medical necessity, or based on whether  the  treatment
    38  is  experimental or investigational; standards for provider admission to
    39  participate in a network, including  reimbursement  rates;  methods  for
    40  determining usual, customary and reasonable charges; exclusions based on
    41  failure  to  complete  a  course of treatment; and restrictions based on
    42  geographic location, facility type, provider specialty, and other crite-
    43  ria that limit the scope or duration of benefits for  services  provided
    44  under the contract; and
    45    (iv)  "chronic  pain" means pain that persists or recurs for more than
    46  three months.
    47    § 3. Section 4303 of the insurance law is  amended  by  adding  a  new
    48  subsection (vv) to read as follows:
    49    (vv)  (1)  Every  contract  issued  by a hospital service corporation,
    50  health service corporation or medical expense indemnity corporation that
    51  includes coverage for pain management services shall provide  outpatient
    52  coverage for non-opioid treatment of chronic pain including complementa-
    53  ry  and  integrative treatments. Access to non-opioid treatment shall be
    54  comparable to that of other covered services. Coverage shall be compara-
    55  ble for services provided by licensed professionals.

        S. 9192                             3

     1    (2) Coverage under this subsection shall not apply financial  require-
     2  ments  or  treatment limitations to non-opioid treatment of chronic pain
     3  that are more restrictive than either of the following: the  predominant
     4  financial requirements and treatment limitations applied to substantial-
     5  ly  all  medical  benefits  covered  by  the contract; and the financial
     6  requirements and  treatment  limitations  applied  to  any  opioid-based
     7  treatment of chronic pain.
     8    (3) For the purposes of this subsection the following terms shall have
     9  the following meanings:
    10    (A)  "financial  requirement"  means deductible, co-payments, co-insu-
    11  rance and out-of-pocket expenses;
    12    (B) "predominant" means that  a  financial  requirement  or  treatment
    13  limitation  is  the  most  common  or  frequent of such type of limit or
    14  requirement;
    15    (C) "treatment limitation" means limits on the frequency of treatment,
    16  number of visits, days of coverage, or other similar limits on the scope
    17  or duration of treatment and includes non-quantitative treatment limita-
    18  tions such as: medical management standards limiting or excluding  bene-
    19  fits  based  on  medical necessity, or based on whether the treatment is
    20  experimental or investigational; standards  for  provider  admission  to
    21  participate  in  a  network,  including reimbursement rates; methods for
    22  determining usual, customary and reasonable charges; exclusions based on
    23  failure to complete a course of treatment;  and  restrictions  based  on
    24  geographic location, facility type, provider specialty, and other crite-
    25  ria  that  limit the scope or duration of benefits for services provided
    26  under the contract; and
    27    (D) "chronic pain" means pain that persists or recurs  for  more  than
    28  three months.
    29    § 4. This act shall take effect the first day of January next succeed-
    30  ing  the  day on which it shall have become a law and shall apply to all
    31  policies and contracts issued, renewed, modified, altered, or amended on
    32  or after such date.
feedback